FIELD: medicine.
SUBSTANCE: invention concerns treatments of disturbances of a primary hemostasis at patients with arterial hypertonia at a metabolic syndrome (MS). For this purpose within 24 weeks carry out the complex treatment including individually picked up hypohigh-calorie diet, and administration of metoprolol preparation in a dose of 100 mg in the morning.
EFFECT: expansion of an arsenal of ways of effective correction thrombocyte hemostasis at sick of a metabolic syndrome; reduction of thrombotic complications at the expense of an optimum combination of not medicamental therapy and specific medicinal preparations in the specified dose during empirically certain course of treatment.
1 ex
